In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

NEED HELP?

Read the Frequently Asked Questions for a better use

READ MORE

 

Refine your search
Sponsor

ESC Congress 365

Your free access to ESC Congress content all year long 

The online library to view thousands of videos, slides, abstracts and reports from the world's largest cardiovascular event – anytime & without subscription!

To make the most of it watch the tutorial video or check out the FAQ!

 

 

ESC Congress 365 only features abstracts, slides, reports and/or videos for which the speakers and/or presenters have granted the European Society of Cardiology the rights to use for educational purposes.

presentations found.

SPONSORED RESOURCES

Presentations below are part of sessions supported by Bayer AG.

Bayer AG
Abstract Slides/e-posters Video Report Interview
 
Practical dimensions of employing oral factor Xa inhibitors in patients with nonvalvular AF: the role of key clinical factors in selecting an evidence-based approach to stroke prevention in AF.
Presenter: S Z Goldhaber (Boston,US)
2015
more
 
Practical issues for use of oral factor Xa inhibition following acute coronary syndrome: risk stratification, patient selection, timing of therapy, bleeding risk reduction, stented patients and long-term management.
Presenter: P G Steg (Paris,FR)
2015
more
 
Program chair welcome and introduction -Practical dimensions of NOAC-based management of stroke prevention in Atrial Fibrillation (AF) and acute coronary syndrome.
Presenter: S Z Goldhaber (Boston,US)
2015
more
 
Q and A - Chronic Thromboembolic Pulmonary Hypertension (CTEPH) - Choosing the right path to successful patient outcomes.
Presenter: J S R Gibbs (London,GB)
2015
more
 
Stroke prevention in high-risk patients with atrial fibrillation in clinical trials.
Presenter: K A A Fox (Nethy Bridge,GB)
2015
more
 
The foundation role of oral factor Xa inhibition for stroke prevention in AF and secondary prevention of acute coronary syndrome: from the registry and guidelines to the practical aspects of cardiovascular care.
Presenter: A Kakkar (London,GB)
2015
more
 
The latest insights from real-life settings on the prevention of atrial fibrillation-related stroke.
Presenter: A J Camm (London,GB)
2015
more
 
Welcome and Introduction - Preventing atrial fibrillation-related strokes and recurrent acute coronary syndromes: combining evidence from clinical trials and real life.
Presenter: C Bode (Freiburg,DE)
2015
more
 
Welcome and Introduction - Translating European Society of Cardiology (ESC) Acute Pulmonary Embolism (PE) Guidelines into clinical practice.
Presenter: A G G Turpie (Dundas,CA)
2015
more
 
Anticoagulant use in patients with atrial fibrillation: daily management challenges.
Presenter: E Hylek (Boston,US)
2014
more

The scientific Programme has been prepared by the Congress Programme Committee in close collaboration with the ESC Working Groups, ESC Associations and the ESC Councils.

 

Bayer AG Bayer HealthCare